Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2019-04-12 2019-04-12
Drug Identification Number 00253952 00253952
Brand name SYNACTHEN DEPOT SYNACTHEN DEPOT
Common or Proper name Tetracosactide Zinc Injection Tetracosactide Zinc Injection
Company Name ATNAHS PHARMA UK LIMITED ATNAHS PHARMA UK LIMITED
Ingredients TETRACOSACTIDE TETRACOSACTIDE
Strength(s) 1MG 1MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 mL ampoule 1 mL ampoule
ATC code H01AA H01AA
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-02-28 2019-02-28
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments